Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Treating chemotherapy-induced neutropenia. The most common complication of chemotherapeutic treatment of cancer is the development of neutropenia owing to bone marrow damage. Low neutrophil levels ...

Late-onset neutropenia (LON) is emerging as a common ... The mechanisms of LON seem to be multifactorial and are related to rituximab-induced B lymphopenia. LON is self-limited in the majority ...

Hand cooling and compression reduced the incidence of grade ≥ 2 chemotherapy-induced peripheral neuropathy (CIPN) by nearly 50% in patients with breast cancer receiving taxane-based chemotherapy.